Indegene Limited is going public with its IPO opening on 6 May 2024. The grey market premium trends are already updated for the upcoming IPO of the company. Interested investors can check out the IPO details, GMO, and other relevant information related to the Indegene IPO.Â
Indegene IPO GMP
Indegene IPO GMP has been updated from the last four sessions. Investors can look into the demand for the Indegene IPO in the unofficial market through the GMP trend.Â
According to the latest update, Indegene’s latest GMP at the time of writing is ₹177 with a price band of 452. The estimated listing price is ₹629 with 39.16% of the expected percentage of loss/gain per share.Â
The GMP trends show the Indegene IPO Retail amount subject to Suada around ₹4400 and for small HNI ₹61600.Â
Here’s the day-wise Indegene IPO GMP trend:
| Date | IPO price | GMP | Subject to Sauda | Estimated Listing Price |
| 30 April 2024 | 452 | ₹177↑ | 4400/61600 | ₹629 |
| 29 April 2024 | 452 | ₹169↓ | 4200/58800 | ₹621 |
| 28 April 2024 | – | ₹170↑ | – | ₹170 |
| 27 April 2024 | – | ₹160 | – | ₹160 |
Indegene IPO Dates
According to the Indegene IPO prospectus, the IPO will open for bidding from 6 May 2024 to 8 May 2024. The allotment of shares will commence on 9 May 2024.Â
The initiation of refunds for the subscribed shares, that were not allotted during the IPO allotment will be refunded to you on 10 May 2024, on the same day the shares will be credited to your demat account. Indegene Limited plans to list the shares after the IPO issue on BSE on 13 May 2024.Â
| Date | Indegene Limited IPO Events |
| 06 May 2024 | IPO Opens |
| 08 May 2024 | IPO closes |
| 09 May 2024 | Allotment of IPO |
| 20 May 2024 | Refund Initiation |
| 13 May 2024 | Listing Date |
| 08 May 2024 | UPI Mandate Confirmation |
Indgene IPO Details
Indegene Limited plans to raise ₹1842.76 crores from the book-built IPO issue. The fresh issue of the IPO contains 16814159 shares that match up to ₹760 crore.Â
According to the RHP prospectus, the total issue size of the Indegene IPO is 40,746,891 shares and the company’s Offers For Sale (OFS) has 2.39 crore shares.Â
The floor price or price band is fixed at ₹430 to ₹452 per equity share with a face value of ₹2 per equity share. We can see, the floor price is 215 times the face value of equity shares.Â
The minimum lot size of the IPO bidding is 33 shares.Â
The registrar of the Indegene IPO is Link Intime India Private Limited and the book-running lead managers decided in the IPO pitch are Citigroup Global Markets India Pvt Ltd., Nomura Financial Advisory and Securities Pvt Ltd, Kotak Mahindra Capital Company Ltd, and JP Morgan India Pvt Ltd.
The company aims to utilize the IPO funds for the loan repayment of its subsidiaries, funding the company’s capital requirements, and other requirements for inorganic growth.
| Company | Indegene Limited |
| IPO Type | Book-built Issue |
| IPO issue Size | 40,746,891 equity shares (matches up to ₹1841,76 Crore) |
| Face Value | ₹2 per equity share |
| Price Band | ₹430 to ₹452 per equity share |
| Lot Size | 33 |
| Fresh Issue | 16,814,159 equity shares (matches up to ₹760 Crore) |
| OFS | 23,932,732 shares (matches up to ₹1081.76 crore |
| Listing at | BSE NSE |
| Employee Discount | ₹30 per share |
Indegene IPO Reservation and Lot Size
The company has reserved the shares offered to each category in the following manner:
| Investor Category | Shares Offered |
| Qualified Institutional Buyers (QIB) | Not exceeding 50% of the net issue |
| Retails | Not less than 35% of the offered shares |
| Non-Institutional Investors (HNI) | Not less than 15% of the offered shares |
The minimum lot size of the Indegene IPO is 33 shares and the retail investor would require a minimum investment of ₹14,916. The minimum lot size for the small NII is 14 with a minimum investment of ₹208,824. Investors can check the lot size distribution among the investor category from the following table:
| Investor Category | Lots | Shares | Amount |
| Retail (min.) | 1 | 33 | ₹14916 |
| Retail (max.) | 13 | 429 | ₹193,908 |
| S-HNI (min.) | 14 | 462 | ₹208,824 |
| S-HNI (max.) | 67 | 2211 | ₹999,372 |
| B-HNI (min.) | 68 | 2244 | ₹1,014,288 |
 Indegene Limited provides digital services for the life sciences sector and they earned more than 69.00% of revenue from operations FY ending on 31 December 2023. The company has a unique business model making them a single player in the market in this sector, so it will be a great choice to invest in the long run.Â